CLOVEN 75MG BOX OF 30

Clopidogrel is indicated for the prevention of events related to atherothrombosis: – In patients suffering from a myocardial infarction (dating from a few days to less than 35 days), a stroke (dating more than 7 days and less than 6 months) or an established arterial occlusive disease of the lower limbs; – In patients with non-ST segment elevation acute coronary syndrome (unstable angina or non-Q wave myocardial infarction), in combination with acetylsalicylic acid (ASA). – Acute myocardial infarction with ST segment elevation, in combination with ASA in medically treated patients eligible for thrombolytic therapy. Prevention of atherothrombotic and thromboembolic events in atrial fibrillation in adult patients with atrial fibrillation, who have at least one risk factor for vascular events that cannot be treated with an anti-vitamin K (VKA) and who have a low risk of bleeding, clopidogrel is indicated, in combination with ASA, for the prevention of atherothrombotic and thromboembolic events, including stroke.